Who are you going to vote as Toronto mayor on October 25?
Rob Ford
Joe Pantalone
Rocco Rossi
George Smitherman
Sarah Thomson
View Results
spotlight Sept 5 -Sept 12, 2010
Zamboni MS treatment is hit and miss
Saskatchewan to fund trials, Ontario says no
By Simona Giacobbi

Saskatchewan’s Health Minister Dan McMorris supports clinical trials.
Saskatchewan was the first. Now supporting the “Zamboni theory” regarding the connection between multiple sclerosis and chronic cerebro-spinal insufficiency (CCSVI) is Manitoba, Nova Scotia, and Quebec.
A chorus of yeses from experts, premiers, and ministers who are now favouring the treatment discovered about 10 years ago by the Ferrarese doctor whose publication late last year was shunned by many.
Almost a month has gone by since the Saskatchewan premier paved the way for research funding. The other provinces are tagging along but so far only with promises. They’re awaiting more concrete results, they say. There’s also the categorical “no” by Ontario Premier Dalton McGuinty.
Meanwhile, Saskatchewan continues to push ahead, as confirmed by the province’s Health Minister Don McMorris.
“We’re a province with one of the highest number of multiple sclerosis cases,” he explained to Corriere Canadese/Tandem. “Some have already undergone tests in Italy and other parts of Europe. They came home talking about the success and effectiveness of the procedure. We want to be the leaders of this research in Canada. Experimentation has been underway for a while in the U.S. Our province has now decided to do it here, ‘challenging’ the research community to take this project forward and finally initiate testing by applying Zamboni’s ‘liberation treatment.’”
Saskatchewan has yet to fix a definitive date to begin the experimentation, awaiting further data from a team of experts.
“The decision is not up to the government,” continued the minister. “The researchers are already at work. We’re hoping to have answers by fall and have testing begin next year.”
In other words, everything is ready in Saskatchewan but there are still many questions to be answered.
“We don’t know precisely how many patients there’ll be to participate in testing,” McMorris said. “I’m not a researcher nor a doctor, therefore it’s absolutely necessary to wait for the directives of those competent in the sector and those who will be conducting the testing to understand the dimension and timetable of the research.”

Page 1/...Page 2

Printable Version Email To A Friend Voice Your Opinion


Home / Back to Top
>> Special Series Archive
>> Contests / Promotions
>> Who We Are
>> Horoscope
>> Job opportunities
>> Advertising
>> Links
>> Search



Sign the online petition
   

Tandem Home | Contact Us | Privacy Policy
© Copyright 2010 Multimedia Nova Corporation All Rights Reserved.